ESR1 and breast carcinoma: Lefebvre et al. reported not only on whole-exome sequencing of 216 advanced breast cancers and noted mutation and amplification of ESR1, but also mutation of clinically actionable genes ERBB4, NOTCH3, and ALK (115).